453 related articles for article (PubMed ID: 28409202)
1. Imaging evaluation of ablative margin and index tumor immediately after radiofrequency ablation for hepatocellular carcinoma: comparison between multidetector-row CT and MR imaging.
Kim SM; Shin SS; Lee BC; Kim JW; Heo SH; Lim HS; Jeong YY
Abdom Radiol (NY); 2017 Oct; 42(10):2527-2537. PubMed ID: 28409202
[TBL] [Abstract][Full Text] [Related]
2. Value of Nonrigid Registration of Pre-Procedure MR with Post-Procedure CT After Radiofrequency Ablation for Hepatocellular Carcinoma.
Park J; Lee JM; Lee DH; Joo I; Yoon JH; Park JY; Klotz E
Cardiovasc Intervent Radiol; 2017 Jun; 40(6):873-883. PubMed ID: 28091728
[TBL] [Abstract][Full Text] [Related]
3. Clinical usefulness of the ablative margin assessed by magnetic resonance imaging with Gd-EOB-DTPA for radiofrequency ablation of hepatocellular carcinoma.
Koda M; Tokunaga S; Okamoto T; Hodozuka M; Miyoshi K; Kishina M; Fujise Y; Kato J; Matono T; Sugihara T; Oyama K; Hosho K; Okano J; Murawaki Y; Kakite S; Yamashita E
J Hepatol; 2015 Dec; 63(6):1360-7. PubMed ID: 26232269
[TBL] [Abstract][Full Text] [Related]
4. Safety margin of radiofrequency ablation for hepatocellular carcinoma: a prospective study using magnetic resonance imaging with superparamagnetic iron oxide.
Fukuda K; Mori K; Hasegawa N; Nasu K; Ishige K; Okamoto Y; Shiigai M; Abei M; Minami M; Hyodo I
Jpn J Radiol; 2019 Jul; 37(7):555-563. PubMed ID: 31102138
[TBL] [Abstract][Full Text] [Related]
5. The minimal ablative margin of radiofrequency ablation of hepatocellular carcinoma (> 2 and < 5 cm) needed to prevent local tumor progression: 3D quantitative assessment using CT image fusion.
Kim YS; Lee WJ; Rhim H; Lim HK; Choi D; Lee JY
AJR Am J Roentgenol; 2010 Sep; 195(3):758-65. PubMed ID: 20729457
[TBL] [Abstract][Full Text] [Related]
6. Ablative margin states by magnetic resonance imaging with ferucarbotran in radiofrequency ablation for hepatocellular carcinoma can predict local tumor progression.
Koda M; Tokunaga S; Miyoshi K; Kishina M; Fujise Y; Kato J; Matono T; Murawaki Y; Kakite S; Yamashita E
J Gastroenterol; 2013 Nov; 48(11):1283-92. PubMed ID: 23338488
[TBL] [Abstract][Full Text] [Related]
7. Does hepatobiliary phase sequence qualitatively outperform unenhanced T1-weighted imaging in assessment of the ablation margin 24 hours after thermal ablation of hepatocellular carcinomas?
Takeyama N; Vidhyarkorn S; Chung DJ; Siripongsakun S; Kim HJ; Lu DS; Raman SS
Abdom Radiol (NY); 2016 Oct; 41(10):1942-55. PubMed ID: 27271219
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of hepatocellular carcinoma ablative margins using fused pre- and post-ablation hepatobiliary phase images.
Takeyama N; Mizobuchi N; Sakaki M; Shimozuma Y; Munechika J; Kajiwara A; Uchikoshi M; Uozumi S; Ohgiya Y; Gokan T
Abdom Radiol (NY); 2019 Mar; 44(3):923-935. PubMed ID: 30327828
[TBL] [Abstract][Full Text] [Related]
9. Prediction of Local Tumor Progression after Radiofrequency Ablation (RFA) of Hepatocellular Carcinoma by Assessment of Ablative Margin Using Pre-RFA MRI and Post-RFA CT Registration.
Yoon JH; Lee JM; Klotz E; Woo H; Yu MH; Joo I; Lee ES; Han JK
Korean J Radiol; 2018; 19(6):1053-1065. PubMed ID: 30386137
[TBL] [Abstract][Full Text] [Related]
10. Assessment of ablative margin after radiofrequency ablation for hepatocellular carcinoma; comparison between magnetic resonance imaging with ferucarbotran and enhanced CT with iodized oil deposition.
Koda M; Tokunaga S; Fujise Y; Kato J; Matono T; Sugihara T; Nagahara T; Ueki M; Murawaki Y; Kakite S; Yamashita E
Eur J Radiol; 2012 Jul; 81(7):1400-4. PubMed ID: 21440397
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the ablation margin of hepatocellular carcinoma using CEUS-CT/MR image fusion in a phantom model and in patients.
Li K; Su Z; Xu E; Huang Q; Zeng Q; Zheng R
BMC Cancer; 2017 Jan; 17(1):61. PubMed ID: 28103837
[TBL] [Abstract][Full Text] [Related]
12. Assessment of ablative margin by unenhanced magnetic resonance imaging after radiofrequency ablation for hepatocellular carcinoma.
Koda M; Tokunaga S; Miyoshi K; Kishina M; Fujise Y; Kato J; Matono T; Okamoto K; Murawaki Y; Kakite S
Eur J Radiol; 2012 Oct; 81(10):2730-6. PubMed ID: 22137612
[TBL] [Abstract][Full Text] [Related]
13. Comparative evaluation of three-dimensional Gd-EOB-DTPA-enhanced MR fusion imaging with CT fusion imaging in the assessment of treatment effect of radiofrequency ablation of hepatocellular carcinoma.
Makino Y; Imai Y; Igura T; Hori M; Fukuda K; Sawai Y; Kogita S; Fujita N; Takehara T; Murakami T
Abdom Imaging; 2015 Jan; 40(1):102-11. PubMed ID: 25052767
[TBL] [Abstract][Full Text] [Related]
14. Three-Dimensional Measurement of Hepatocellular Carcinoma Ablation Zones and Margins for Predicting Local Tumor Progression.
Hocquelet A; Trillaud H; Frulio N; Papadopoulos P; Balageas P; Salut C; Meyer M; Blanc JF; Montaudon M; Denis de Senneville B
J Vasc Interv Radiol; 2016 Jul; 27(7):1038-1045.e2. PubMed ID: 27156743
[TBL] [Abstract][Full Text] [Related]
15. Comparison of gadoxetic acid-enhanced MR imaging versus four-phase multi-detector row computed tomography in assessing tumor regression after radiofrequency ablation in subjects with hepatocellular carcinomas.
Yoon JH; Lee EJ; Cha SS; Han SS; Choi SJ; Juhn JR; Kim MH; Lee YJ; Park SJ
J Vasc Interv Radiol; 2010 Mar; 21(3):348-56. PubMed ID: 20116285
[TBL] [Abstract][Full Text] [Related]
16. Contrast-enhanced US-guided radiofrequency ablation of hepatocellular carcinoma.
Rajesh S; Mukund A; Arora A; Jain D; Sarin SK
J Vasc Interv Radiol; 2013 Aug; 24(8):1235-40. PubMed ID: 23796857
[TBL] [Abstract][Full Text] [Related]
17. Coronal reformatted CT images contribute to the precise evaluation of the radiofrequency ablative margin for hepatocellular carcinoma.
Motoyama T; Ogasawara S; Chiba T; Higashide T; Yokota H; Kanogawa N; Suzuki E; Ooka Y; Tawada A; Irie R; Ochi S; Masuda Y; Uno T; Yokosuka O
Abdom Imaging; 2014 Apr; 39(2):262-8. PubMed ID: 24346490
[TBL] [Abstract][Full Text] [Related]
18. 3D fusion is superior to 2D point-to-point contrast-enhanced US to evaluate the ablative margin after RFA for hepatocellular carcinoma.
Long H; Zhou X; Zhang X; Ye J; Huang T; Cong L; Xie X; Huang G
Eur Radiol; 2024 Feb; 34(2):1247-1257. PubMed ID: 37572191
[TBL] [Abstract][Full Text] [Related]
19. The tumor ghost on MRI after microwave ablation for hepatocellular carcinoma: A new modality to assess the ablative margin.
Liu S; Wu J; Ding W; Zhang C; Luo Y; Bai X; Wen K; Han Z; Yu J; Liang P
Eur J Radiol; 2023 Jan; 158():110617. PubMed ID: 36463706
[TBL] [Abstract][Full Text] [Related]
20. Postablation assessment using follow-up registration of CT images before and after radiofrequency ablation (RFA): prospective evaluation of midterm therapeutic results of RFA for hepatocellular carcinoma.
Shin S; Lee JM; Kim KW; Joo I; Han JK; Choi BI; Klotz E
AJR Am J Roentgenol; 2014 Jul; 203(1):70-7. PubMed ID: 24951197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]